Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
The Verge18d
Here’s OpenAI’s new logo
OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...
pharmaphorum2d
Boehringer says R&D pipeline is the best in its long history
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
pharmaphorum2d
Boehringer licenses Sosei schizophrenia drugs in €755m deal
Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...
Sports Illustrated20d
NHL Fans Roast Utah Hockey Club Over Proposed Logos for New Franchise Nickname
On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...
Australian Broadcasting Corporation18d
Australia grants PNG $570 million loan amid push for stricter foreign investment scrutiny
As part of the deal, PNG has agreed to tighten foreign investment screening and block economically unviable or high-risk projects. Papua New Guinea's government has promised not to push ahead with ...
BioSpace13d
Boehringer Ingelheim’s Lung Fibrosis Drug Scores Second Late-Stage Win
Boehringer plans to submit for FDA and other global approvals in both indications. Boehringer Ingelheim recorded a second straight Phase III win Monday for its drug nerandomilast, which met the ...
BioSpace3d
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
RIDGEFIELD, Conn., Feb. 20, 2025 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today the appointment of Brian Hilberdink as President, U.S. Human Pharma. His arrival comes at a ...
precisionmedicineonline4d
FDA Accepts Boehringer Ingelheim's New Drug Application for HER2-Targeted Therapy in NSCLC
NEW YORK – Boehringer Ingelheim on Wednesday said the US Food and Drug Administration accepted its new drug application for the irreversible tyrosine kinase inhibitor zongertinib as a treatment for ...
inkbotdesign.com5d
The 7 Different Types Of Logos & How To Use Them
It is essential to understand the 7 different types of logos and when to use them. Each type has strong and weak points - Need professional help? Ever wonder why some logos stick in your mind like ...